ADC THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Sept 2025)
What this means for you
This application is over — abandoned 15 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90301418
- Mark type
- Stylized text
- Filed
- 05 Nov 2020
- Published for opposition
- 14 Jun 2022
- Abandoned
- 15 Sept 2025
- Attorney of record
- Tracy-Gene G. Durkin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans
Owner
- ADC Therapeutics SA, Epalinges, CH
- ADC Therapeutics SA, Epalinges, CH
Prior registrations
Prosecution history
- 15 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2025 — SOU EXTENSION 5 GRANTED
- 07 Feb 2025 — SOU EXTENSION 5 FILED
- 07 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 06 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Aug 2024 — SOU EXTENSION 4 GRANTED
- 06 Aug 2024 — SOU EXTENSION 4 FILED
- 06 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 09 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2024 — CORRECTED NOA E-MAILED
- 08 Mar 2024 — SOU EXTENSION 3 GRANTED
- 08 Feb 2024 — SOU EXTENSION 3 FILED
- 08 Mar 2024 — DIVISIONAL PROCESSING COMPLETE